Physician profile
Lan Luo
NPI 1295938975
$11,257.51
in general payments reported to CMS, 2019-2025
48 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $2,393 · 2021: $1,426 · 2022: $2,489 · 2023: $1,389 · 2024: $1,214 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,683.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,043.65 | 2019-2025 | |
| Astrazeneca Uk Limited | $1,000.00 | 2022 | |
| Amgen INC. | $892.84 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $739.89 | 2019-2025 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $620.32 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $544.55 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $535.82 | 2020-2025 | Nexletol |
| Pfizer INC. | $496.91 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $456.40 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.54 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $327.92 | 2019-2025 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $304.60 | 2019-2023 | |
| Lexicon Pharmaceuticals, INC. | $268.17 | 2023-2024 | Inpefa |
| Abbott Laboratories | $260.84 | 2019-2025 | Aveir, Jot Dx, Mitraclip |
| Boston Scientific Corporation | $249.33 | 2019-2025 | Watchman Flx, Varithena Administration Pack, Resonate El Icd Vr |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $219.70 | 2020-2025 | Ecc Solutions, (Cm9) Amb Mon & Diag Und |
| Alnylam Pharmaceuticals INC. | $219.49 | 2022-2025 | Onpattro, Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $207.12 | 2019-2024 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $175.74 | 2019-2023 | |
| Novo Nordisk INC | $152.55 | 2021-2024 | Ozempic |
| Astellas Pharma US INC | $109.17 | 2019-2021 | |
| Edwards Lifesciences Corporation | $94.53 | 2022-2024 | Sapien 3 Ultra Resilia |
| United Therapeutics Corporation | $93.72 | 2024-2025 | Tyvaso, Tyvaso |
| Medtronic Vascular, INC. | $88.16 | 2019-2020 | |
| Lundbeck LLC | $80.46 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $76.23 | 2022-2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $72.40 | 2023 | Assure Wcd |
| Baxter Healthcare | $58.33 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic, INC. | $58.25 | 2022-2023 | Linq II |
| Abiomed | $48.76 | 2023-2025 | Impella |
| Ionis Pharmaceuticals, INC. | $48.25 | 2025 | Tryngolza |
| Bayer Healthcare Pharmaceuticals INC. | $42.86 | 2025 | |
| Biotronik INC. | $38.00 | 2019 | |
| Cvrx, INC. | $36.88 | 2024 | Barostim Neo System |
| Cashflow Solutions, LLC | $36.41 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Daiichi Sankyo INC. | $22.12 | 2025 | Injectafer |
| Amryt Pharma Holdings LTD | $20.67 | 2021 | |
| Cleerly, INC. | $20.07 | 2023 | Cleerly Labs |
| Tactile Systems Technology INC | $18.15 | 2025 | Nimbl, Flexitouch Plus |
| Bard Peripheral Vascular, INC. | $15.05 | 2024 | Venclose Maven Catheter |
| Biocompatibles, INC. | $13.98 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.68 | 2021 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$65,932.34 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lan Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.